Patients with macular degeneration show improvement with high-dose statin treatment

A phase I/II clinical trial has found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration. AMD is the leading cause of blindness in the developed world, and though effective treatments are available for the wet AMD, they are currently lacking for the more-prevalent dry form.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1QkaHVb